Home › Trial NCT05370235
A Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Xeroderma Pigmentosum C and V
- Trial IDNCT05370235
- StatusUnknown
- PhasePhase 2
- Study typeInterventional
- SponsorClinuvel Europe Limited
- Enrollment6
- Start date2022-03-28
- ConditionsXeroderma Pigmentosum
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.